Awaysis Capital, Inc.
AWCA News Today: Stay Updated with the Latest Awaysis Capital, Inc. News in Real Time
Find AWCA news now at Meyka AI. Stay informed with the latest Awaysis Capital, Inc. stocks updates, including price news, market analysis, and expert insights.
Goldman Sachs Maintained Buy on Loar Holdings Inc (LOAR) Feb 26, 2026
Goldman Sachs maintained Buy on Loar Holdings; latest LOAR analyst rating and implications Feb 26, 2026
GANGOTRI.NS INR 0.61 Gangotri Textiles NSE 27 Feb 2026: Oversold bounce case
Intraday oversold bounce for GANGOTRI.NS stock at INR 0.61 on 27 Feb 2026 with short target INR 0.80
ADS.F adidas AG (XETRA) up 2.63% pre-market 27 Feb 2026: earnings focus on margin recovery
ADS.F stock jumps pre-market ahead of 04 Mar earnings; our earnings spotlight and forecast track margin and revenue drivers
February 27: U.S. Mortgage Rates Drop Below 6%, Refi Jumps as Buyers Pause
U.S. mortgage rates today near 6% spur a 4% refi surge and 5% drop in purchases. What it means for UK investors, lenders, homebuilders, and rates.
579.SI stock down 25% intraday 27 Feb 2026 (SES): key price levels to watch
Intraday update on 579.SI stock: S$0.003, -25.00% on 27 Feb 2026; quick analysis and outlook
LTHM.CN Champion Electric Metals CNQ down 50% on 27 Feb 2026: liquidity risk ahead
LTHM.CN stock falls to CAD 0.005 on CNQ. Quick analysis, Meyka AI forecast and key risks
Netflix Pulls Out of Warner Bros. Bid, Clearing Path for Paramount Global
On February 26, 2026, Netflix officially stepped away from its bid for Warner Bros. Discovery, ending weeks of intense deal speculation. The decision came after Paramount Global, backed by Skydance, raised its offer, pushing the valuation far higher. For Netflix, the price no longer made financial sense. This move instantly reshaped the media merger race…
Jetstar Pressure, Air NZ Loss Put NZ Airfares in Focus — February 27
Jetstar pressure and Air New Zealand’s NZ$40m loss put NZ airfares in focus for Japan-based travelers. We explain drivers, policy risk, fare outlook, and steps to watch.
Jefferies Maintains Buy, PT $45 for Viridian Therapeutics (VRDN) Feb 2026
VRDN analyst rating: Jefferies maintains Buy with $45 PT and Evercore keeps Outperform in Feb 2026